EUCTR 2009‐016317‐20‐IT.

Trial name or title	Pilot study to assess safety and tolerability of lithium on spinocerebellar ataxia of type 2 ‐ lithium in SCA2
Methods	Double‐blind, placebo‐controlled, parallel‐group, randomised pilot clinical trial
Participants	Inclusion criteria: molecular diagnosis of SCA2, age > 18 years
Interventions	Hard capsule oral lithium carbonate 300 mg or placebo
Outcomes	Main objective: safety and tolerability of lithium in SCA2 Primary end point(s): serious and non serious adverse events safety laboratory parameters Secondary objective: effect of lithium on clinical measures
Starting date	26 October 2009
Contact information	Not provided
Notes	—